A global controversy regarding the drug and its efficacy as a prophylactic against Covid-19 or even as a treatment began with studies in respectable journals, the Lancet and the New England Journal of Medicine, questioning its use and hinting it could increase mortality rates among patients with a heart condition.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3dJsets
No comments:
Post a Comment